We are live on ! Find out more
TPI

TIANYIN PHARMACEUTICAL
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

Back to rankings

6 hedge funds and large institutions have $1.69M invested in TIANYIN PHARMACEUTICAL in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 9 → 6 (-3)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

44% less capital invested

Capital invested by funds: $3.03M → $1.69M (-$1.34M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$47.4K
2
RIM
Regent Investment Management
Kentucky
+$515

Top Sellers

Rank Fund Capital Flow
1
PAM
Pope Asset Management
Tennessee
-$549K
2
VKH
Virtu KCG Holdings
New York
-$39K
3
RCM
Rotella Capital Management
Washington
-$30K
4
Citadel Advisors
Citadel Advisors
Florida
-$16.4K
5
CS
Credit Suisse
Switzerland
-$15K

TPI Hedge Fund Activity: Q2 2014 in Review

6 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q2 2014, worth a combined $1.69M — down 44% from $3.03M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of TPI and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $47.4K. The largest seller was Pope Asset Management, cutting an estimated $549K.

  • 6 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q2 2014, down from 9 in Q1 2014.
  • Funds reported $1.69M of TIANYIN PHARMACEUTICAL stock for Q2 2014, down 44% quarter-over-quarter.
  • 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q2 2014 and 3 closed out, a net change of -3 holders.
  • The largest TIANYIN PHARMACEUTICAL buyer in Q2 2014 was Renaissance Technologies, an estimated $47.4K added.
  • The largest TIANYIN PHARMACEUTICAL seller in Q2 2014 was Pope Asset Management, an estimated $549K sold.

Based on aggregated 13F filings for Q2 2014.